BioJapan 2019 | Pharma Conference in Japan 2019
Discover the prism of opportunities
Let’s discuss the Business challenges and find their solution over a cup of coffee.
Book A One-To-One Meeting With Our Delegates At BIO-Japan 2019.
BIO JAPAN Pacifico Yokohama 2019
BIO-Japan is the largest partnering event in Asia for Global Biotechnology industry. To facilitate Japanese healthcare companies surge their presence globally and expand their foot base all over the world, BIO-Japan Pacifico Yokohama, renders them with a platform to discuss the potential opportunities in the Healthcare market and the impending associated challenges.
Pacifico Yokohama Japan officially known as Pacific Convention Plaza Yokohama, is a world class convention and exhibition center in Nishi-ku, Yokohama, Kanagawa, Japan.
Located in the western tip of waterfront Minato Mirai 21 district, Pacifico Yokohama Japan events also are famous for offering picturesque views. The Pacifico Yokohama Japan convention center is a new landmark of the city Yokohama, adorned with stimulating architecture enthused with motifs of waves, wind and light.
The Bio Japan conference center is an integrated gateway between the whole world and Japan. Enriched with all the convention facilities, Pacific Convention Plaza Yokohama has the seating of 5,000 with 50 meeting rooms of various sizes. Pacifico Yokohama North offers a complete range of functions for MICE engagements.
The BIO JAPAN Pacifico Yokohama conference is all-in-one source for all the global companies to strive forward in their respective healthcare domain and different geographies.
Bio Japan Pacifico Yokohama is the region’s much talked-about conference for companies that are engaged in biotechnology, pharmaceutical, healthcare, novel medicine, medical technology, and medicine research, etc.
The year Bio Japan 2018 experienced an overwhelming response from all over the world with a total of 16,309 visitors from more than 34 countries.
The 2019 Bio Japan conference is being reiterated for the 21st time and has been encouragingly inspiring several pharma companies to explore new business opportunities.
Business professionals, R&D analysts, healthcare leaders and KOLs from over 1,000 organizations worldwide are going to make their Business prosper by attending the event and holding over 10,000 anticipated meetings.
Japan Healthcare Industry, and Medical Reforms
The high-class 3-day event is the longest conference in Japan and successfully attracts delegates from domestic, as well as overseas Healthcare companies. The success of the event is reflected in the form large number of participants. Such great response can be attributed to amendments and reforms done to accelerate the Drug value chain in Japan.
The landmark Pharmaceuticals and Medical Devices Act (PMD Act) and the Act on the Safety of Regenerative Medicine has led to a quicker marketing approval of the drugs for better and faster commercialization.
Moreover, Japan, along with being recognized as inherent of the fastest approval system, also has a speedier process of approving medical advancements and technologies in healthcare.
Japan aims to be the center of the Regenerative medicine. And it is taking leaps towards achieving it goals. Since the year these reforms were made in the year 2014, Japan has seen a flood of Pharmaceutical and Biotech companies globally interested in partnerships, mergers, and licensing their products. At the moment, Japan is the World’s largest market for pharmaceuticals.
Japan Vision: Healthcare 2035
The whole idea of the Japan’s healthcare system is to build a Healthcare system that’s is sustainable and drives a better outcome. Japan has over the time worked on it and at the moment Japan medical sector contributes to the GDP of the Japan.
Being the World’s third largest economy, Japan healthcare is believed to be the finest in the World. Japanese have the longest life-expectancy and are at liberty to choose their own healthcare insurance.
Furthermore, according to a WHO report, Japan has made an appreciating number of successes in the Healthcare. This includes the decrease in the accidental deaths from past 50 years, and eradication of common infectious diseases.
Japan’s Healthcare Market is taking leaps
Japan’s Healthcare Market is booming. Going by the data presented by World Bank, Japan approximately spent 10.2% of it’s GDP on Healthcare in the year 2017. As the demand for better healthcare surges, the healthcare expenditure is likely to increase at a quicker pace in the coming years. Moreover, according to OECD, the pharmaceutical spending made up 21% of total health spending in 2011- the tenth-highest share out of the 32 OECD countries surveyed in that year.
Japan invests the largest share, i.e., 1.1% of its GDP in the health which is double the OECD average of 0.5%. And the capital investment in healthcare will further expediate due to the introduction of novel innovative technologies in healthcare.
Why is DelveInsight attending the BIO JAPAN Pacifico Yokohama 2019?
DelveInsight, one of the emerging providers of Healthcare consulting and market research, provides advisory services, market analysis, competitive benchmarking, forecast services, and congress intelligence to companies in the Life Science vertical.
DelveInsight is recognized for its customized, syndicated research reports, and business consulting services to healthcare, pharmaceuticals and biotech companies which invest a lot of time and money during the developmental phase of their drug candidates. With an active and dedicated team of in-house experts and KOLs, DelveInsight manages to successfully support and guide the healthcare domain by easing up this tiresome process by helping them take business-oriented decisions that fortify their foundation in this fast-evolving life science market. The company gauge the fast-paced market and help the clients to withstand in the rapidly growing pharma market. The company delivers high-quality insights on prevailing and upcoming pharma market scenario through its in-depth and exhaustive market analysis. The comprehensive pharma market analysis proffered by DelveInsight helps the biotech companies to forecast market future based on the analysis of past and present market scenario. The forecasts present a detailed analysis of patient shares, access rates, market shares, peak shares, market trends, drug uptake and so on. Healthcare consulting companies help clients by delivering high-quality insights on prevailing and upcoming market scenario through their Competitive Intelligence (CI).